Ipsen Late-Breaking Data Raises Ambitions In PBC

By Reuters News

- Ipsen SA IPN.PA:

  • LATE-BREAKING DATA RAISES AMBITIONS IN PBC WITH MORE THAN 85% OF PATIENTS ON TREATMENT ACHIEVING ALP NORMALIZATION

  • AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED WITH 23.3% RECEIVING PLACEBO

Further company coverage: IPN.PA

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk